Codex DNA Overview
- Founded
- 2013
- Status
- Public
- Employees
- 133
- Stock Symbol
- DNAY
- Investments
- 1
- Share Price
- $8.32
- (As of Monday Closing)
Codex DNA General Information
Description
Codex DNA Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide.
Contact Information
Website
www.codexdna.com
Formerly Known As
SGI-DNA
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
- 9535 Waples Street
- Suite 100
- San Diego, CA 92121-2993
- United States
+1 (858) 000-0000
Codex DNA Timeline
Codex DNA Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $8.32 | $9.13 | $6.16 - $25.70 | $268M | 29.3M | 609K | -$2.07 |
Codex DNA Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|
| EV | 219,989 | ||
| Revenue | 9,902 | 6,576 | 4,805 |
| EBITDA | (29,389) | (15,858) | |
| Net Income | (32,050) | (18,010) | |
| Total Assets | 124,494 | 26,863 | 38,761 |
| Total Debt | 15,601 | 8,326 | 4,768 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Codex DNA Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Codex DNA‘s full profile, request access.
Request a free trialCodex DNA Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
This information is available in the PitchBook Platform. To explore Codex DNA‘s full profile, request access.
Request a free trialCodex DNA Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Codex DNA Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly bu
Discovery Tools (Healthcare)
San Diego, CA
133
As of 2021
00000
0000
0000-00-00
00000000
00000
00000000
olor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore mag
0000 000000000
Menlo Park, CA
000
As of 0000
00000
0000
0000-00-00
00000000
00000
00000000
prehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
0000000000000
San Diego, CA
00
As of 0000
000.00
0000000000
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialCodex DNA Competitors (8)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Personalis | Formerly VC-backed | Menlo Park, CA | 000 | 00000 | 00000000 | 00000 |
| 000000000 00000000 | Venture Capital-Backed | San Diego, CA | 00 | 000.00 | 0000000000 | 000.00 |
| 00000000000 | Corporate Backed or Acquired | Bothell, WA | 000000&0 | |||
| 00000 0000000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 00000000 | 00000 |
| 00000000 000000 00 | Formerly VC-backed | Baltimore, MD | 000 | 00000 | 000000&0 | 00000 |
Codex DNA Patents
Codex DNA Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210277446-A1 | Methods for assembling nucleic acids | Pending | 03-Mar-2020 | 0000000000 | |
| US-20210284954-A1 | Vibrio sp. organisms with modified lipopolysaccharide | Pending | 20-Nov-2017 | 000000000 | |
| CA-3082589-A1 | Vibrio sp. organisms with modified lipopolysaccharide | Pending | 20-Nov-2017 | 000000000 | |
| AU-2018367359-A1 | Vibrio sp. organisms with modified lipopolysaccharide | Pending | 20-Nov-2017 | 000000000 | |
| US-20190153554-A1 | Vibrio sp. organisms with modified lipopolysaccharide | Granted | 20-Nov-2017 | C12R1/63 | 0 |
Codex DNA Executive Team (8)
Codex DNA Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| Andrea Jackson | Northpond Ventures | Board Member | 000 0000 |
| Andrew Lee Ph.D | Northpond Ventures | Board Director | 000 0000 |
| Christine Tsingos | Codex DNA | Board Member | 000 0000 |
| Frank Witney Ph.D | Self | Board Member | 000 0000 |
| Jami Nachtsheim | Self | Board Member | 000 0000 |
Codex DNA Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCodex DNA Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Codex DNA‘s full profile, request access.
Request a free trialCodex DNA Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 00000000 | 09-Nov-2021 | 0000000000 | 0000 | Biotechnology | 0000 0000 |